# Optimized Therapy in Severe Traumatic Brain Injured Patients

> **NCT02130674** · PHASE4 · COMPLETED · sponsor: **University of Zurich** · enrollment: 12 (actual)

## Conditions studied

- Traumatic Brain Injury
- Coma

## Interventions

- **DRUG:** Dipeptiven

## Key facts

- **NCT ID:** NCT02130674
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130674, "Optimized Therapy in Severe Traumatic Brain Injured Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02130674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*